Overview

rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

Status:
Terminated

Trial end date:
2020-04-08

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the tolerability and preliminary efficacy of rhDNase I eye drops in patients with ocular Graft-vs.-Host disease (oGVHD).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of Illinois at Chicago

Collaborators:

Genentech, Inc.
National Eye Institute (NEI)

Treatments:

Ophthalmic Solutions
Tetrahydrozoline